These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31831922)

  • 1. Effect of a polyherbal formulation in streptozotocin-induced diabetic nephropathy in wistar rats.
    Reddy KS; Sudheer A; Pradeepkumar B; Reddy CS
    Indian J Pharmacol; 2019; 51(5):330-336. PubMed ID: 31831922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice.
    Yu SH; Dubey NK; Li WS; Liu MC; Chiang HS; Leu SJ; Shieh YH; Tsai FC; Deng WP
    PLoS One; 2016; 11(11):e0166342. PubMed ID: 27832180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidiabetic and protective effects of Scrophularia striata ethanolic extract on diabetic nephropathy via suppression of RAGE and S100A8 expression in kidney tissues of streptozotocin-induced diabetic rats.
    Alaee M; Akbari A; Karami H; Salemi Z; Amri J; Panahi M
    J Basic Clin Physiol Pharmacol; 2020 Jan; 31(2):. PubMed ID: 31967963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic and antihyperlipidemic activities of a novel polyherbal formulation in high fat diet/streptozotocin induced diabetic rat model.
    Subhasree N; Kamella A; Kaliappan I; Agrawal A; Dubey GP
    Indian J Pharmacol; 2015; 47(5):509-13. PubMed ID: 26600639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of coenzyme Q10 alone and its combination with metformin on streptozotocin-nicotinamide-induced diabetic nephropathy in rats.
    Maheshwari RA; Balaraman R; Sen AK; Seth AK
    Indian J Pharmacol; 2014; 46(6):627-32. PubMed ID: 25538335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
    Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of Astragaloside IV on endoplasmic reticulum stress-induced renal tubular epithelial cells apoptosis in type 2 diabetic nephropathy rats.
    Ju Y; Su Y; Chen Q; Ma K; Ji T; Wang Z; Li W; Li W
    Biomed Pharmacother; 2019 Jan; 109():84-92. PubMed ID: 30396095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin glycosides from Hydrangea paniculata slow down the progression of diabetic nephropathy by targeting Nrf2 anti-oxidation and smad2/3-mediated profibrosis.
    Sen Z; Weida W; Jie M; Li S; Dongming Z; Xiaoguang C
    Phytomedicine; 2019 Apr; 57():385-395. PubMed ID: 30849675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of telmisartan with sildenafil ameliorate progression of diabetic nephropathy in streptozotocin-induced diabetic model.
    El-Mahdy NA; El-Sayad ME; El-Kadem AH
    Biomed Pharmacother; 2016 Jul; 81():136-144. PubMed ID: 27261587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibition ameliorates nephropathy in an animal model of type 2 diabetes: focus on oxidative stress, inflammation, and fibrosis.
    Zakaria EM; El-Maraghy NN; Ahmed AF; Ali AA; El-Bassossy HM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):621-631. PubMed ID: 28224182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic and renoprotective effect of Anogeissus acuminata leaf extract on experimentally induced diabetic nephropathy.
    Navale AM; Paranjape A
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):359-364. PubMed ID: 29617268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angelica acutiloba root alleviates advanced glycation end-product-mediated renal injury in streptozotocin-diabetic rats.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Food Sci; 2011 Sep; 76(7):H165-74. PubMed ID: 22417553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of oxymatrine on experimental diabetic nephropathy.
    Guo C; Han F; Zhang C; Xiao W; Yang Z
    Planta Med; 2014 Mar; 80(4):269-76. PubMed ID: 24535719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats.
    Ge J; Miao JJ; Sun XY; Yu JY
    J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (Hoelen Five Herb Formula), a traditional Chinese prescription.
    Liu IM; Tzeng TF; Liou SS; Chang CJ
    J Ethnopharmacol; 2009 Jul; 124(2):211-8. PubMed ID: 19397971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
    Zabad IEM; Amin MN; El-Shishtawy MM
    Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ameliorative effect of eprosartan on high-fat diet/streptozotocin-induced early diabetic nephropathy in rats.
    Morsy MA; Heeba GH; Mahmoud ME
    Eur J Pharmacol; 2015 Mar; 750():90-7. PubMed ID: 25625658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
    Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
    J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study.
    Yang X
    Drug Deliv; 2019 Dec; 26(1):849-859. PubMed ID: 31524015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.